Headlines about KEMET (NYSE:KEM) have trended somewhat positive this week, according to Accern. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. KEMET earned a media sentiment score of 0.08 on Accern’s scale. Accern also gave media headlines about the electronics maker an impact score of 45.5591891984146 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
KEM has been the subject of several recent analyst reports. B. Riley upped their target price on KEMET from $22.50 to $24.75 and gave the company a “buy” rating in a report on Friday, February 2nd. ValuEngine raised KEMET from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Finally, Zacks Investment Research raised KEMET from a “sell” rating to a “hold” rating in a report on Thursday, January 4th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $19.58.
KEMET (NYSE KEM) opened at $19.81 on Friday. The stock has a market capitalization of $1,120.00, a P/E ratio of 3.97 and a beta of 3.60. The company has a quick ratio of 1.74, a current ratio of 2.49 and a debt-to-equity ratio of 0.70. KEMET has a twelve month low of $10.70 and a twelve month high of $27.35.
KEMET (NYSE:KEM) last released its earnings results on Thursday, February 1st. The electronics maker reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.16. KEMET had a return on equity of 22.51% and a net margin of 28.33%. The company had revenue of $306.40 million during the quarter, compared to analyst estimates of $295.68 million. During the same period in the prior year, the company posted $0.11 earnings per share. KEMET’s quarterly revenue was up 63.0% on a year-over-year basis. analysts anticipate that KEMET will post 1.62 EPS for the current year.
In related news, SVP Ronald James Assaf sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 14th. The stock was sold at an average price of $16.89, for a total value of $337,800.00. Following the transaction, the senior vice president now owns 94,225 shares in the company, valued at $1,591,460.25. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO William M. Lowe, Jr. sold 24,700 shares of the company’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $16.93, for a total value of $418,171.00. Following the completion of the transaction, the chief financial officer now owns 461,570 shares in the company, valued at approximately $7,814,380.10. The disclosure for this sale can be found here. In the last quarter, insiders sold 140,532 shares of company stock worth $2,534,291. 3.88% of the stock is owned by company insiders.
COPYRIGHT VIOLATION NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Impact KEMET (KEM) Stock Price” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://ledgergazette.com/2018/03/18/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-kemet-kem-stock-price.html.
KEMET Corporation (KEMET) is a manufacturer of passive electronic components. The Company operates in two segments: Solid Capacitors, and Film and Electrolytic. The Solid Capacitors segment primarily produces tantalum, aluminum, polymer and ceramic capacitors. Solid Capacitors also produces tantalum powder used in the production of tantalum capacitors.
Receive News & Ratings for KEMET Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KEMET and related companies with MarketBeat.com's FREE daily email newsletter.